Edward Rosilla, Priefer Ronny
Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA.
Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA.
Prim Care Diabetes. 2023 Oct 27. doi: 10.1016/j.pcd.2023.10.009.
As diabetes prevalence has continued to increase in the United States, as well as globally, utilization of disease management techniques has also improved. The evolution in disease management for diabetes has adapted greatly from the initial dipstix method. Continuous glucose monitors have grown in popularity with its introduction to the market. After introduction of CGMs as part of DM management, various advancements have been made to the current models to promote the usage CGMs to promote glycemic control. The main competitors in the CGM market is Medtronic, Dexcom, Freestyle, and Eversense.
Information was primarily gathered by employing various PubMed scholarly articles for real-world examples in addition to data extraction from supplementary manuscripts. Articles were evaluated from over the past 20 years.
Clinically improvement of disease management of blood glucose levels, specifically with regards to mean absolute relative difference (MARD) was utilized to highlight effectiveness of continuous glucose monitors.
Of the four key continuous glucose monitors device on the market in the US, all have demonstrated to have similar beneficial qualities which can be utilized in both T1DM and T2DM patients. The best device for an individual would be based on their specific diabetes management goal (maintain TIR, decreasing TBR/TAR, decrease A1c).
随着美国以及全球糖尿病患病率持续上升，疾病管理技术的应用也有所改善。糖尿病疾病管理已从最初的尿糖试纸法有了很大发展。连续血糖监测仪自投放市场以来越来越受欢迎。在将连续血糖监测仪作为糖尿病管理的一部分引入后，当前型号已取得了各种进展，以促进连续血糖监测仪的使用，从而改善血糖控制。连续血糖监测仪市场的主要竞争对手是美敦力、德康、优泌乐和艾弗森斯。
除了从补充手稿中提取数据外，主要通过使用各种PubMed学术文章来获取实际案例信息。对过去20年的文章进行了评估。
利用血糖水平疾病管理的临床改善，特别是平均绝对相对差（MARD）来突出连续血糖监测仪的有效性。
在美国市场上的四种主要连续血糖监测仪设备中，所有设备都已证明具有相似的有益特性，可用于1型糖尿病和2型糖尿病患者。对个人来说，最佳设备将取决于其特定的糖尿病管理目标（维持目标血糖范围内时间、降低血糖波动幅度、降低糖化血红蛋白）。
